CUV1647
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CUV1647, covering 2011-10-05 to 2011-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)